REDWOOD CITY, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, ...
Greetings, and welcome to the Codexis Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note that this conference is being recorded. I will now turn the conference over to ...
Hosted on MSN
Codexis reiterates $64M–$68M 2025 revenue guidance while exploring ECO Synthesis expansion
Management reiterated the 2025 guidance of $64 million to $68 million in revenue, with expectations that the "bulk of the growth to come from our ligase and our ECO Synthesis business for the second ...
REDWOOD CITY, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback